Associated Papers
Listerin promotes α-synuclein degradation to alleviate Parkinson's disease through the ESCRT pathway.
Qin F et al.
Science Advances, 2025
In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease.
da Silva ANR et al.
Journal of Cellular Biochemistry, 2024
Monitoring α-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation.
Zenko D et al.
Science Advances, 2023
Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.
Hmila I et al.
The Febs Journal, 2022
Differences in the binding of copper(I) to α- and β-synuclein.
De Ricco R et al.
Inorganic Chemistry, 2015
Sumoylation inhibits alpha-synuclein aggregation and toxicity.
Krumova P et al.
The Journal of Cell Biology, 2011
Sequence determinants regulating fibrillation of human alpha-synuclein.
Koo HJ et al.
Biochemical and Biophysical Research Communications, 2008
Secondary structure and dynamics of micelle bound beta- and gamma-synuclein.
Sung YH et al.
Protein Science : a Publication of the Protein Society, 2006
Genetic algorithm for analysis of mutations in Parkinson's disease.
Smigrodzki R et al.
Artificial Intelligence in Medicine, 2005
Select a paper to view details